FDA NDC Directory · JSON-LD · Markdown

ELAHERE

NDC 72903-853 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameMIRVETUXIMAB SORAVTANSINE
Labeler / ManufacturerImmunoGen, Inc.
Marketing categoryBiologic License Application · App BLA761310
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsMIRVETUXIMAB SORAVTANSINE (5 mg/mL)
Marketing started20221114
Package count1

External sources

Source: openFDA. Public-domain (CC0).